NIOX has acquired 3 companies. A total of 2 acquisitions came from private equity firms.
NIOX’s largest acquisition to date was in 2015, when it acquired Aerocrine AB for $211M. NIOX has acquired in 2 countries. The Company’s most targeted sectors include healthcare services (50%) and medical products (50%).
Hayakawa Building, Edmund Halley Road, The Oxford Science Park,
Oxford,
OX4 4GB
United Kingdom,
+44 3303 309 356
www.niox.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2015-05-18 |
Prosonix Ltd. · Medical Products
Oxford, United Kingdom · www.prosonix.co.uk Prosonix is a UK specialty pharmaceutical company focused on the development of a range of product candidates for the treatment of asthma and COPD. Prosonix's portfolio is based on its proprietary particle engineering technology and Prosonitron reactor system, which enables precise control of pharmaceutical product crystallisation during manufacture, and subsequent delivery characteristics. |
154 | Add-on Acquisition |
GIMV
PE
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
